78 related articles for article (PubMed ID: 12757618)
1. NIM-R7, a novel marker for resting B1 and marginal-zone B lymphocytes, is also expressed on activated T and B cells.
Manjarrez-Orduño N; Parkhouse RM; Santos-Argumedo L
Immunology; 2003 Jun; 109(2):232-7. PubMed ID: 12757618
[TBL] [Abstract][Full Text] [Related]
2. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells.
Oliver AM; Martin F; Kearney JF
J Immunol; 1999 Jun; 162(12):7198-207. PubMed ID: 10358166
[TBL] [Abstract][Full Text] [Related]
3. Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells.
Won WJ; Foote JB; Odom MR; Pan J; Kearney JF; Davis RS
J Immunol; 2006 Nov; 177(10):6815-23. PubMed ID: 17082595
[TBL] [Abstract][Full Text] [Related]
4. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms.
Amano M; Baumgarth N; Dick MD; Brossay L; Kronenberg M; Herzenberg LA; Strober S
J Immunol; 1998 Aug; 161(4):1710-7. PubMed ID: 9712035
[TBL] [Abstract][Full Text] [Related]
5. CD44-stimulated dendrite formation ('spreading') in activated B cells.
Santos-Argumedo L; Kincade PW; Partida-Sánchez S; Parkhouse RM
Immunology; 1997 Jan; 90(1):147-53. PubMed ID: 9038725
[TBL] [Abstract][Full Text] [Related]
6. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody NIM-R3 substitutes for B-cell growth factor.
Greenwood MR; Parkhouse RM
Immunology; 1986 Sep; 59(1):7-13. PubMed ID: 3489671
[TBL] [Abstract][Full Text] [Related]
8. IgG1 production by sIgD+ splenic B cells and peritoneal B-1 cells in response to IL-5 and CD38 ligation.
Yasue T; Baba M; Mori S; Mizoguchi C; Uehara S; Takatsu K
Int Immunol; 1999 Jun; 11(6):915-23. PubMed ID: 10360965
[TBL] [Abstract][Full Text] [Related]
9. Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses.
Cuenca M; Romero X; Sintes J; Terhorst C; Engel P
J Immunol; 2016 Jan; 196(2):726-37. PubMed ID: 26667173
[TBL] [Abstract][Full Text] [Related]
10. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.
Hamaguchi Y; Uchida J; Cain DW; Venturi GM; Poe JC; Haas KM; Tedder TF
J Immunol; 2005 Apr; 174(7):4389-99. PubMed ID: 15778404
[TBL] [Abstract][Full Text] [Related]
11. Characterization of two monoclonal antibodies (UCL4D12 and UCL3D3) that discriminate between human mantle zone and marginal zone B cells.
Smith-Ravin J; Spencer J; Beverley PC; Isaacson PG
Clin Exp Immunol; 1990 Oct; 82(1):181-7. PubMed ID: 2208792
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells.
Snapper CM; Yamada H; Smoot D; Sneed R; Lees A; Mond JJ
J Immunol; 1993 Apr; 150(7):2737-45. PubMed ID: 7681079
[TBL] [Abstract][Full Text] [Related]
13. Presentation of antigen by B cells subsets. I. Lyb-5+ and Lyb-5- B cells differ in ability to stimulate antigen specific T cells.
Zimecki M; Whiteley PJ; Pierce CW; Kapp JA
Arch Immunol Ther Exp (Warsz); 1994; 42(2):115-23. PubMed ID: 7503644
[TBL] [Abstract][Full Text] [Related]
14. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells.
Mariani SM; Krammer PH
Eur J Immunol; 1998 May; 28(5):1492-8. PubMed ID: 9603453
[TBL] [Abstract][Full Text] [Related]
15. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.
Rickert RC; Rajewsky K; Roes J
Nature; 1995 Jul; 376(6538):352-5. PubMed ID: 7543183
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of CD22 (Lyb8) on murine B cells.
Erickson LD; Tygrett LT; Bhatia SK; Grabstein KH; Waldschmidt TJ
Int Immunol; 1996 Jul; 8(7):1121-9. PubMed ID: 8757957
[TBL] [Abstract][Full Text] [Related]
17. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
Shen GL; Li JL; Vitetta ES
J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
[TBL] [Abstract][Full Text] [Related]
18. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice.
Donís-Hernández FR; Parkhouse RM; Santos-Argumedo L
Eur J Immunol; 2001 Apr; 31(4):1261-7. PubMed ID: 11298353
[TBL] [Abstract][Full Text] [Related]
19. B cell subpopulations in the mouse: analysis with monoclonal antibodies NIM-R2 and NIM-R3.
Chayen A; Parkhouse RM
Eur J Immunol; 1982 Sep; 12(9):725-32. PubMed ID: 6982819
[TBL] [Abstract][Full Text] [Related]
20. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC
Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
